These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9679999)

  • 1. Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method.
    Hunink MG; Bult JR; de Vries J; Weinstein MC
    Med Decis Making; 1998; 18(3):337-46. PubMed ID: 9679999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis.
    Hunink MG; Wong JB; Donaldson MC; Meyerovitz MF; de Vries J; Harrington DP
    JAMA; 1995 Jul; 274(2):165-71. PubMed ID: 7596006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial.
    Collins CD; Schwemm AK
    Value Health; 2015 Jul; 18(5):614-21. PubMed ID: 26297089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later.
    Tuffaha HW; Roberts S; Chaboyer W; Gordon LG; Scuffham PA
    Appl Health Econ Health Policy; 2015 Apr; 13(2):167-79. PubMed ID: 25650349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal artery stenosis: cost-effectiveness of diagnosis and treatment.
    van Helvoort-Postulart D; Dirksen CD; Nelemans PJ; Kroon AA; Kessels AG; de Leeuw PW; Vasbinder GB; van Engelshoven JM; Hunink MG
    Radiology; 2007 Aug; 244(2):505-13. PubMed ID: 17581886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N; Schneider H
    J Endovasc Ther; 2013 Dec; 20(6):819-25. PubMed ID: 24325699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada.
    Tarride JE; Blackhouse G; De Rose G; Novick T; Bowen JM; Hopkins R; O'Reilly D; Goeree R
    J Vasc Surg; 2008 Oct; 48(4):779-87. PubMed ID: 18639421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
    Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous stenting of incidental unilateral renal artery stenosis: decision analysis of costs and benefits.
    Axelrod DA; Fendrick AM; Carlos RC; Lederman RJ; Froehlich JB; Weder AB; Abrahamse PH; Stanley JC
    J Endovasc Ther; 2003 Jun; 10(3):546-56. PubMed ID: 12932167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
    de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
    Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of computed tomographic angiography before reoperative coronary artery bypass grafting: a decision-analytic model.
    Gada H; Desai MY; Marwick TH
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):705-10. PubMed ID: 22933521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of the determination of autoantibodies against cyclic citrullinated peptide in the early diagnosis of rheumatoid arthritis.
    Konnopka A; Conrad K; Baerwald C; König HH
    Ann Rheum Dis; 2008 Oct; 67(10):1399-405. PubMed ID: 18192304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost--utility analysis of treatment options for inguinal hernia in 1,513,008 adult patients.
    Stylopoulos N; Gazelle GS; Rattner DW
    Surg Endosc; 2003 Feb; 17(2):180-9. PubMed ID: 12415334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States.
    Bosch JL; Haaring C; Meyerovitz MF; Cullen KA; Hunink MG
    AJR Am J Roentgenol; 2000 Aug; 175(2):517-21. PubMed ID: 10915706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease--decision analysis.
    Nolan B; Finlayson S; Tosteson A; Powell R; Cronenwett J
    J Vasc Surg; 2007 Jun; 45(6):1179-84. PubMed ID: 17543682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group.
    Bosch JL; Tetteroo E; Mali WP; Hunink MG
    Radiology; 1998 Sep; 208(3):641-8. PubMed ID: 9722840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies.
    Radcliff K; Lerner J; Yang C; Bernard T; Zigler JE
    J Neurosurg Spine; 2016 May; 24(5):760-8. PubMed ID: 26824587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.